Press Releases
May 16, 2011 - NeuroHealing Announces Strategic Master Services and Investment Agreement with Cato BioVentures
February 10, 2011 - Cato Research Expands Relationship with Merge Healthcare to include myEDC™ for Early Phase Trials
January 10, 2011
Advanced Pain Remedies, a Subsidiary of Cato BioVentures, Announces a Three Million Dollar Award from the National Cancer Institute for SP-SAPDecember 20, 2010
VistaGen Therapeutics Announces Successful Completion of Initial Phase 1 Safety Study of AV-101 for Neuropathic PainNovember 1, 2010
Cato Research Partners with BioClinica for Clinical Trial Management System (CTMS)September 27, 2010
Advanced Targeting Systems Announces $3 Million Award from National Cancer InstituteMay 20, 2010
Merge Healthcare and Cato Research Ltd. Establish New Five-Year Technology Transfer Agreement